Search Results 621-630 of 2171 for 查论文ai率的网站,ai人工智能网址,图片ai生成网站,免费的ai写作网站,ai绘画动漫网站,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

1. Mooney Mori, M.D., Ph.D. - Mayo Clinic Faculty Profiles

   Mooney Mori, M.D., Ph.D., is a physician-scientist at Mayo Clinic specializing in organ generative medicine and end-stage lung disease treatments.

2. A Study of MPDL3280A (Anti-PD-L1 Antibody) Combined with Carboplatin and Paclitaxel , and with or without Bevacizumab, for Patients who have Stage IV Non-Squamous Non-Small Cell Lung Cancer - Mayo Clinic

   A Study of MPDL3280A (Anti-PD-L1 Antibody) Combined with Carboplatin and Paclitaxel , and with or without Bevacizumab, for Patients who have Stage IV Non- ...

3. Mayo Clinic Upper Digestive Disease Survey

   Data will contribute to creating treatment algorithms for symptom management for upper digestive diseases and for post-operative complications and symptoms as ...

4. Collaborators - Brain Adaptation and Stimulation: Brian N. Lundstrom - Mayo Clinic Research

   Collaborators. Dr. Lundstrom's team collaborates and shares support staff with the Bioelectronics Neurophysiology and Engineering Laboratory of Gregory A.

5. Collaborators - Molecular Analysis of Human Diseases Laboratory - Mayo Clinic Research

   Collaborators. Dr. Hawse is involved in ongoing research collaborations at Mayo Clinic and other institutions. Mayo Clinic collaborators. Breast cancer.

6. Training Opportunities - Human Immunodeficiency Virus Lab: Andrew D. Badley - Mayo Clinic Research

   Mayo Clinic offers several education programs for aspiring researchers.

7. GS-4997 in Adults With Pulmonary Arterial Hypertension - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

8. A Study of CG-806 in Patients with Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   The purpose of this study is to assess the safety, tolerability and preliminary efficacy of nal-IRI in combination with 5-FU/LV and oxaliplatin in patients not ...

10. Yajue Huang, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Yajue Huang, M.D., Ph.D., a Mayo Clinic researcher, has a long-standing research career in diagnostic cancer pathology.